Skip to content

Drug interactions

Gemfibrozil + Irinotecan liposomal

Severity: Major

Gemfibrozil and Irinotecan liposomal: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Gemfibrozil inhibits UGT1A1, the enzyme that glucuronidates SN-38, the active metabolite of irinotecan. Higher SN-38 exposure may intensify neutropenia and severe diarrhea.

What this interaction means in plain words

Gemfibrozil and Irinotecan liposomal can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Inhibition of UGT1A1-mediated glucuronidation of SN-38 raises levels of the active metabolite.

What to do

Avoid combining where possible and use another lipid-lowering agent during irinotecan therapy. If unavoidable, monitor blood counts and diarrhea closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Gemfibrozil and Irinotecan liposomal, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Gemfibrozil with Irinotecan liposomal?

MediHelp rates the interaction as major. Gemfibrozil and Irinotecan liposomal can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Gemfibrozil inhibits UGT1A1, the enzyme that glucuronidates SN-38, the active metabolite of irinotecan. Higher SN-38 exposure may intensify neutropenia and severe diarrhea.

How serious is the interaction between Gemfibrozil and Irinotecan liposomal?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining where possible and use another lipid-lowering agent during irinotecan therapy. If unavoidable, monitor blood counts and diarrhea closely.

What other medicines interact with Gemfibrozil?

MediHelp also lists interactions of Gemfibrozil with, for example, Daprodustat, Elagolix, Mavacamten. The full list is on the Gemfibrozil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in